Labcorp Expands Diagnostic Reach With Strategic Deal For Select Assets Of BioReference Health
Portfolio Pulse from Akanksha Bakshi
Laboratory Corporation Of America Holdings (NYSE:LH) has acquired select operations of Opko Health, Inc's (NASDAQ:OPK) subsidiary BioReference Health. The deal, valued at $237.5 million, involves assets generating about $100 million in annual revenue. This acquisition aims to expand Labcorp's diagnostic services reach, excluding New York and New Jersey, and is expected to enhance patient and physician experiences by providing broader access to Labcorp's laboratory services and testing capabilities. OPK shares rose 12.14% to $1.20 following the announcement.
March 28, 2024 | 3:41 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Labcorp acquires select operations of BioReference Health from Opko Health, aiming to expand its diagnostic services reach and enhance patient and physician experiences.
The acquisition of BioReference Health's assets by Labcorp is likely to positively impact LH's stock in the short term due to the expansion of its service network and the potential for increased revenue from the acquired assets. The strategic move to enhance its diagnostic services and testing capabilities could be viewed favorably by investors.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Opko Health's shares rose 12.14% to $1.20 following the announcement of selling select operations of its subsidiary BioReference Health to Labcorp.
Opko Health's stock price increase of 12.14% following the asset sale announcement indicates a positive short-term impact. The sale could be perceived as a strategic move to streamline operations and focus on core services, potentially leading to sustained growth and profitability as indicated by OPKO's CEO.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80